These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 196132)

  • 1. [Drug treatment of hyperlipemia in middle-aged and old persons with ischemic heart disease].
    Semavin IE; Goliakov VN; Solov'ev VV
    Kardiologiia; 1977 Mar; 17(3):77-83. PubMed ID: 196132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypolipemic effect of diosponine in ischemic heart disease depending on the type of hyperlipoproteinemia].
    Zakharov VN
    Kardiologiia; 1977 Jun; 17(6):136-7. PubMed ID: 197285
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness of new lipotropic preparations in hyperlipemia].
    Miasnikov LA; Bavina MV; Lobova NM; Koropova GI
    Kardiologiia; 1971 Aug; 11(8):26-30. PubMed ID: 5160871
    [No Abstract]   [Full Text] [Related]  

  • 4. Gemfibrozil therapy in primary hypertriglyceridemia associated with coronary heart disease. Effects on metabolism of low-density lipoproteins.
    Vega GL; Grundy SM
    JAMA; 1985 Apr; 253(16):2398-403. PubMed ID: 3856692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of ischemic heart disease with a hypolipoproteinemic drug pericit].
    Britov AN; Shmushkovich BI; Karmanskiĭ IM
    Kardiologiia; 1977 Jun; 17(6):87-91. PubMed ID: 197290
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of miskleron in ischemic heart disease with differing types of hyperlipoproteinemias].
    Krivoruchenko IV; Nikul'cheva NG
    Kardiologiia; 1976 Jul; 16(7):71-5. PubMed ID: 185448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The importance of determining the type of hyperlipidemia for lipotropic therapy of atherosclerosis].
    Bavina MV; Perova NV; Lobova NM; Koropova GI
    Kardiologiia; 1973 Mar; 13(3):27-33. PubMed ID: 4717180
    [No Abstract]   [Full Text] [Related]  

  • 8. [Types of hyperlipoproteinemia in young persons with ischemic heart diseases engaged in strenuous mental work].
    Krivoruchenko IV; Nikul'cheva NG; Kukuĭ LM; Bermiakova AS
    Kardiologiia; 1977 Jun; 17(6):74-9. PubMed ID: 197287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
    Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL
    J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atilipidemic drugs. Part 5: Evaluation of the hypolipidemic effect of LF 178 in 191 patients affected by the atherogenic form of endogenous hyperlipoproteinemia (types IIa, IIb and IV).
    Rouffy J; Dreux C; Goussault Y; Dakkak R; Renson FJ
    Arzneimittelforschung; 1976; 26(5):901-6. PubMed ID: 183788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red grape seed extract improves lipid profiles and decreases oxidized low-density lipoprotein in patients with mild hyperlipidemia.
    Razavi SM; Gholamin S; Eskandari A; Mohsenian N; Ghorbanihaghjo A; Delazar A; Rashtchizadeh N; Keshtkar-Jahromi M; Argani H
    J Med Food; 2013 Mar; 16(3):255-8. PubMed ID: 23437789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Micronized fenofibrate, decreased triglyceride levels, total cholesterol and LDL fractions in serum].
    Zaborska B; Kłoś J; Sikora-Frac M; Cybulska B; Ceremuzyński L
    Pol Arch Med Wewn; 2000 Jul; 104(1):371-5. PubMed ID: 11303327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Typology of the hyperlipoproteinemias in ischemic heart disease].
    Zakharova VN; Afanas'eva ON; Andrushchenko ES; Naumova LV; Zarudina IN
    Kardiologiia; 1977 Dec; 17(12):105-8. PubMed ID: 202776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signs of coronary atherosclerosis in apparently healthy men with different types of hyperlipoproteinaemia.
    Olsson AG
    Postgrad Med J; 1975; 51(8):40-3. PubMed ID: 1221379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in serum lipoproteins in patients with ischemic heart disease at an early age].
    Malamov E; Kiriakov A; Tsenov I; Kavrukova Iu; Kusitasev G
    Vutr Boles; 1982; 21(2):91-8. PubMed ID: 7101895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of prodectin and lipoic acid on the lipid metabolism indicators in chronic ischemic heart disease].
    Grigor'ian VA; Klantsa NA; Prishliak VD; Klantsa PN
    Vrach Delo; 1981 Oct; (10):13-5. PubMed ID: 6795820
    [No Abstract]   [Full Text] [Related]  

  • 17. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM; Levy RI
    Cardiovasc Clin; 1974; 6(2):1-8. PubMed ID: 4374303
    [No Abstract]   [Full Text] [Related]  

  • 18. Risks for hyperlipidemia.
    Nestruck AC; Davignon J
    Cardiol Clin; 1986 Feb; 4(1):47-56. PubMed ID: 2871933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of a new synthetic compound (3-nicotinoyl-oxypropyl p-chlorophenoxy isobutyrate: I.612) on plasma lipids in patients with type IIa, IIb and IV hyperdyslipidemia].
    Bucalossi A; Buzzelli G; D'Alessandro A
    Clin Ter; 1979 Apr; 89(2):127-49. PubMed ID: 226307
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyperlipoproteinemia in angiographically documented coronary artery disease.
    Eisenberg S; Tzivoni D; Stern S
    Eur J Cardiol; 1976 Dec; 4(4):469-73. PubMed ID: 187428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.